Using the same RNAsequencing data from ZCC and McGill University we assessed SLC3A2 expression in DIPG and found significantly higher SLC3A2 expression in DIPG tumor samples (n = 45) compared to fetal-derived normal brain tissue (n = 11) (Fig. 2a, Supplementary Table 3). Here, SLC3A2 is linked to neoplasm.